数字农科院2.0

Immunogenicity and protective efficacy of an inactivated bivalent vaccine containing two recombinant H1N1 and H3N2 swine influenza virus strains

文献类型： 外文期刊

作者： Zhang, Heng;Chen, Xu;Liu, Dongying;Liu, Xinyu;Ge, Yifan;Sun, Yani;Zhang, Xiaoyue;Hao, Guangen;Li, Zhaoyang;Song, Qingqing;Wang, Lei;Wang, Zhao;Yang, Huanliang;Pan, Qing;Zhao, Qin

作者机构：

关键词： Swine influenza virus;Immune duration;Protective efficacy

期刊名称： CELLULAR AND MOLECULAR LIFE SCIENCES

ISSN： 1420-682X

年卷期： 2025 年 82 卷 1 期

页码：

收录情况： SCIE（2025版）

摘要： The wild-type H1N1 and H3N2 swine influenza virus (SIV) strains are unsuitable for vaccine production because of high lethality in chicken embryos and low reproductive titers. This study developed recombinant H1N1-Re1 and H3N2-Re1 strains via HA and NA genes from the wild-type H1N1 SW/GX/755/17 and H3N2 SW/GX/1659/17 strains combined with six internal genes from the H1N1 A/PR/8/34 strain. The recombinant viruses demonstrated typical cytopathic effects in MDCK cells, and the presence of viral particles was confirmed via electron microscopy. Growth curve analysis revealed titers of 108.31 and 108.17 EID50 per 100 mu L for H1N1-Re1 and H3N2-Re1, respectively, within 72-96 h postinoculation. Virus stocks were used to produce a bivalent inactivated vaccine. After two immunizations, hemagglutination inhibition titers in piglets were significantly greater than those induced by commercial vaccines and were sustained from 5 to 29 weeks postimmunization. Upon challenge with virulent wild-type SIV strains, viral isolation occurred in all pigs in the PBS group (5/5 protection), whereas no virus was detected in the bivalent vaccine group (0/5). In contrast, the commercial vaccine group had a viral isolation rate of 1/5. Pathological examination revealed severe pulmonary lesions in the PBS group, mild changes in the commercial vaccine group (1/5), and normal lung morphology in the bivalent vaccine group. This study demonstrated the successful application of an eight-plasmid reverse genetics system to develop recombinant vaccine strains with enhanced immunogenicity and replication efficiency. The bivalent inactivated vaccine provides prolonged and complete protection against H1N1 and H3N2 SIV strains, offering a robust tool for controlling evolving SIV variants.

分类号：

  • 相关文献

[1]Protective efficacy of a high-growth reassortant swine H3N2 inactivated vaccine constructed by reverse genetic manipulation. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Tong, Guang-Zhi.

[2]PA-X protein contributes to virulence of triple-reassortant H1N2 influenza virus by suppressing early immune responses in swine. Xu, Guanlong,Zhang, Xuxiao,Hu, Zhe,Sun, Honglei,Xiong, Xin,Jiang, Ming,He, Qiming,Wang, Yu,Pu, Juan,Guo, Xin,Yang, Hanchun,Liu, Jinhua,Sun, Yipeng,Xu, Guanlong,Zhang, Xuxiao,Hu, Zhe,Sun, Honglei,Xiong, Xin,Jiang, Ming,He, Qiming,Wang, Yu,Pu, Juan,Guo, Xin,Yang, Hanchun,Liu, Jinhua,Sun, Yipeng,Xu, Guanlong,Liu, Qinfang,Bing, Guoxia.

[3]A novel M2e-multiple antigenic peptide providing heterologous protection in mice. Wen, Feng,Ma, Ji-Hong,Yu, Hai,Yang, Fu-Ru,Huang, Meng,Zhou, Yan-Jun,Li, Ze-Jun,Wang, Xiu-Hui,Li, Guo-Xin,Jiang, Yi-Feng,Tong, Wu,Tong, Guang-Zhi.

[4]The Tyrosine 73 And Serine 83 Dephosphorylation Of H1N1 Swine Influenza Virus Ns1 Protein Attenuates Virus Replication And Induces High Levels Of Beta Interferon. Tao, Jie,Li, Benqiang,Shi, Ying,Shi, Ying,Tao, Jie,Cheng, Jinghua,Liu, Huili,Shi, Ying,Li, Benqiang,Liu, Huili,Li, Benqiang,Cheng, Jinghua,Liu, Huili,Tao, Jie,Cheng, Jinghua. 2019

[5]PA-X protein decreases replication and pathogenicity of swine influenza virus in cultured cells and mouse models. Gong, Xiao-Qian,Ruan, Bao-Yang,Liu, Xiao-Min,Wang, Qi,Yang, Hai-Ming,Wang, Shuai-Yong,Zhang, Peng,Wang, Xiu-Hui,Shan, Tong-Ling,Tong, Wu,Zhou, Yan-Jun,Li, Guo-Xin,Zheng, Hao,Tong, Guang-Zhi,Yu, Hai,Sun, Ying-Feng,Shan, Tong-Ling,Tong, Wu,Zhou, Yan-Jun,Li, Guo-Xin,Zheng, Hao,Tong, Guang-Zhi,Yu, Hai.

[6]Novel triple reassortant H1N2 influenza viruses bearing six internal genes of the pandemic 2009/H1N1 influenza virus were detected in pigs in China. Qiao, Chuanling,Liu, Liping,Yang, Huanliang,Chen, Yan,Xu, Huiyang,Chen, Hualan.

[7]A recombinant pseudorabies virus encoding the HA gene from H3N2 subtype swine influenza virus protects mice from virulent challenge. Tian, ZJ,Zhou, GH,Zheng, BL,Qiu, HJ,Ni, JQ,Yang, HL,Yin, XN,Hu, SP,Tong, GZ. 2006

[8]Protective efficacy of an inactivated Eurasian avian-like H1N1 swine influenza vaccine against homologous H1N1 and heterologous H1N1 and H1N2 viruses in mice. Sui, Jinyu,Yang, Dawei,Qiao, Chuanling,Xu, Huiyang,Xu, Bangfeng,Wu, Yunpu,Yang, Huanliang,Chen, Yan,Chen, Hualan.

[9]Immune Efficacy Of An Adenoviral V.ector-Based Swine Influenza Vaccine A gainst Antigenically Distinct H1N1 Strains In Mice. Wu, YP, Yang, DW, Xu, BF, Liang, WH, Sui, JY, Chen, Y, Yang, HL, Chen, HL, Wei, P, Qiao, CL. 2017

[10]Characterization Of Monoclonal Antibodies Against H.a Protein Of H1N1 S wine Influenza Virus And Protective Efficacy Against H1 Viruses In Mice. Liu, Y, Li, HT, Xue, YJ, Zhao, S, Li, CX, Qu, LD, Zhang, Y, Liu, M. 2017

[11]Development Of A Novel Oil-In-Water E.mulsion And Evaluation Of I ts Potential Adjuvant Function In A Swine Influenza Vaccine In Mice. Zhang, JQ, Miao, JF, Han, XA, Lu, Y, Deng, BH, Lv, F, Zhao, YH, Ding, C, Hou, JB. 2018

[12]Pa-X Protein Decreases Replication And P.athogenicity Of Swine Influenza V irus In Cultured Cells And Mouse Models. Gong, XQ, Sun, YF, Ruan, BY, Liu, XM, Wang, Q, Yang, HM, Wang, SY, Zhang, P, Wang, XH, Shan, TL, Tong, W, Zhou, YJ, Li, GX, Zheng, H, Tong, GZ, Yu, H. 2017

[13]The Pb2-K627E Mutation Attenuates H3N2 S.wine Influenza Virus In C ultured Cells And In Mice. Gong, XQ, Ruan, BY, Liu, XM, Zhang, P, Wang, XH, Wang, Q, Shan, TL, Tong, W, Zhou, YJ, Li, GX, Zheng, H, Tong, GZ, Yu, H. 2018

[14]The Role Of Pa-X C-Terminal 20 Residues Of Classical Swine Influenza Virus In Its Replication And Pathogenicity. Wang, XH, Gong, XQ, Wen, F, Ruan, BY, Yu, LX, Liu, XM, Wang, Q, Wang, SY, Wang, J, Zhang, YF, Zhou, YJ, Shan, TL, Tong, W, Zheng, H, Kong, N, Yu, H, Tong, GZ. 2020

[15]Immune Escape Adaptive Mutations in Hemagglutinin Are Responsible for the Antigenic Drift of Eurasian Avian-Like H1N1 Swine Influenza Viruses. Xu, Chengzhi,Zhang, Naixin,Yang, Yuying,Liang, Wenhua,Zhang, Yaping,Wang, Jingfei,Suzuki, Yasuo,Wu, Yunpu,Chen, Yan,Yang, Huanliang,Qiao, Chuanling,Chen, Hualan. 2022

[16]Protective Efficacy Of A Bivalent Inactivated Reassortant H1N1 Influenza Virus Vaccine Against European Avian-Like And Classical Swine Influenza H1N1 Viruses In Mice. Ruan, BY, Yao, Y, Wang, SY, Gong, XQ, Liu, XM, Wang, Q, Yu, LX, Zhu, SQ, Wang, J, Shan, TL, Zhou, YJ, Tong, W, Zheng, H, Li, GX, Gao, F, Kong, N, Yu, H, Tong, GZ. 2020

[17]Two amino acid residues in the N-terminal region of the polymerase acidic protein determine the virulence of Eurasian avian-like H1N1 swine influenza viruses in mice. Yang, Yuying,Xu, Chengzhi,Zhang, Naixin,Wan, Yunfei,Wu, Yunpu,Meng, Fei,Chen, Yan,Yang, Huanliang,Liu, Liling,Qiao, Chuanling,Chen, Hualan. 2024

[18]Isolation and Characterization of H1 Subtype Swine Influenza Viruses Recently Circulating in China. Minghao Yan,Tianxin Ma,Xiaona Shi,Qin Chen,Luzhao Li,Bangfeng Xu,Xue Pan,Qiaoyang Teng,Chunxiu Yuan,Dawei Yan,Zhifei Zhang,Qinfang Liu,Zejun Li. 2025

[19]Protective efficacy of pVAX-RON5p against acute and chronic infections of Toxoplasma gondii in BALB/c mice. Zhao, Yu,Li, Zhong-Yuan,Chen, Jia,Liu, Shan-Shan,Zhu, Xing-Quan,Zhou, Dong-Hui,Zhao, Yu,Sun, Xiao-Lin,Li, Zhong-Yuan,Liu, Shan-Shan,Zhu, Xing-Quan.

[20]Deletion of the BAC sequences from recombinant meq-null Marek's disease (MD) virus increases immunosuppression while maintaining protective efficacy against MD. Su, S.,Cui, N.,Sun, P.,Cui, Z.,Li, J.,Li, H.,Li, Y..

作者其他论文 更多>>